How long is long enough? Timing of pre-conceptional remission predicts relapse risk during pregnancy in IBD - Quiz - MDSpire

How long is long enough? Timing of pre-conceptional remission predicts relapse risk during pregnancy in IBD

  • By

  • Dianne G Bouwknegt

  • Birgit Hoekstra

  • Hylke C Donker

  • Bram van Es

  • Henk Groen

  • Gerard Dijkstra

  • Willemijn A van Dop

  • Tjebbe Tauber

  • C Janneke van der Woude

  • Marijn C Visschedijk

  • Dutch Initiative on Crohn and Colitis (ICC)

  • Alexander Bodelier

  • Lauranne Derikx

  • Willemijn van Dop

  • Marjolijn Duijvestein

  • Noortje Festen

  • Herma Fidder

  • Rogier Goetgebuer

  • Carmen Horjus

  • Jeroen Jansen

  • Bindia Jharap

  • Vincent de Jonge

  • Mark Löwenberg

  • Nofel Mahmmod

  • Sander van der Marel

  • Wout Mares

  • Peter Mensink

  • Andrea van der Meulen

  • Zlatan Mujagic

  • Loes Nissen

  • Liekele Oostenburg

  • Marieke Pierik

  • Tessa Römkens

  • Fiona van Schaik

  • Xavier Smeets

  • Marijn Visschedijk

  • Michael van der Voorn

  • Philip Voorneveld

  • Annemarie de Vries

  • Rachel West

  • Egbert-Jan van der Wouden

  • October 13, 2025

  • 0 min

Share

Original Source(s)

How long is long enough? Timing of pre-conceptional remission predicts relapse risk during pregnancy in IBD

  • by Dianne G Bouwknegt, Birgit Hoekstra, Hylke C Donker, Bram van Es, Henk Groen, Gerard Dijkstra, Willemijn A van Dop, Tjebbe Tauber, C Janneke van der Woude, Marijn C Visschedijk, Dutch Initiative on Crohn and Colitis (ICC), Alexander Bodelier, Lauranne Derikx, Willemijn van Dop, Marjolijn Duijvestein, Noortje Festen, Herma Fidder, Rogier Goetgebuer, Carmen Horjus, Jeroen Jansen, Bindia Jharap, Vincent de Jonge, Mark Löwenberg, Nofel Mahmmod, Sander van der Marel, Wout Mares, Peter Mensink, Andrea van der Meulen, Zlatan Mujagic, Loes Nissen, Liekele Oostenburg, Marieke Pierik, Tessa Römkens, Fiona van Schaik, Xavier Smeets, Marijn Visschedijk, Michael van der Voorn, Philip Voorneveld, Annemarie de Vries, Rachel West, Egbert-Jan van der Wouden

  • October 13, 2025

Related Content

Advanced Crohn’s Therapies Show Similar Safety

Large claims analysis finds no significant differences in serious infections, blood clots, or major cardiovascular events across biologics and a Janus kinase inhibitor.

Ethosuximide vs Placebo for IBS Pain

Randomized trial found no improvement in abdominal pain and higher discontinuation rates with the calcium channel blocker.

Strategies for Organ Regeneration Using Cell Therapy